Kestra Advisory Services, LLC Neogenomics Inc Transaction History

Kestra Advisory Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $38,313 - $45,752	-2,725 Reduced 7.96%	31,520 $495,000
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $306,921 - $545,199	-26,300 Reduced 43.44%	34,245 $554,000
Q3 2023 Nov 09, 2023	BUY	$12.15 - $17.85 $531,562 - $780,937	43,750 Added 260.49%	60,545 $744,000
Q2 2023 Aug 11, 2023	BUY	$14.1 - $19.83 $236,809 - $333,044	16,795 New	16,795 $269,000
Q4 2021 Jan 20, 2022	SELL	$30.49 - $48.49 $169,219 - $269,119	-5,550 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$41.66 - $52.52 $10,581 - $13,340	254 Added 4.8%	5,550 $267,000
Q2 2021 Jul 28, 2021	SELL	$36.62 - $51.69 $71,482 - $100,898	-1,952 Reduced 26.93%	5,296 $239,000
Q1 2021 May 10, 2021	BUY	$41.56 - $59.88 $5,111 - $7,365	123 Added 1.73%	7,248 $349,000
Q4 2020 Jan 20, 2021	BUY	$36.08 - $56.47 $257,070 - $402,348	7,125 New	7,125 $386 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.